Global Home and Alternate Site Infusion Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 86

Published Date: 08 Jan 2022

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Home and Alternate Site Infusion Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Home and Alternate Site Infusion Therapy market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during review period. Residential accounting for  % of the Home and Alternate Site Infusion Therapy global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Chemotherapy segment is altered to a  % CAGR between 2022 and 2028.

Global key companies of Home and Alternate Site Infusion Therapy include Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, and McLaren, etc. In terms of revenue, the global top four players hold a share over  % in 2021.

Market segmentation
Home and Alternate Site Infusion Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Chemotherapy
    Anti-infective Therapies
    Immune Therapy
    General Nursing Services
    Others

Market segment by Application, can be divided into
    Residential
    Ambulatory Infusion Centers
    Others

Market segment by players, this report covers
    Option Care Health
    Coram CVS
    UnitedHealth Group
    HCA Healthcare
    McLaren
    CHI Health
    Accredo Health
    PharMerica
    Cleveland Clinic

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Home and Alternate Site Infusion Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Home and Alternate Site Infusion Therapy, with revenue, gross margin and global market share of Home and Alternate Site Infusion Therapy from 2019 to 2022.
Chapter 3, the Home and Alternate Site Infusion Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Home and Alternate Site Infusion Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Home and Alternate Site Infusion Therapy research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Home and Alternate Site Infusion Therapy
    1.2 Classification of Home and Alternate Site Infusion Therapy by Type
        1.2.1 Overview: Global Home and Alternate Site Infusion Therapy Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Home and Alternate Site Infusion Therapy Revenue Market Share by Type in 2021
        1.2.3 Chemotherapy
        1.2.4 Anti-infective Therapies
        1.2.5 Immune Therapy
        1.2.6 General Nursing Services
        1.2.7 Others
    1.3 Global Home and Alternate Site Infusion Therapy Market by Application
        1.3.1 Overview: Global Home and Alternate Site Infusion Therapy Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Residential
        1.3.3 Ambulatory Infusion Centers
        1.3.4 Others
    1.4 Global Home and Alternate Site Infusion Therapy Market Size & Forecast
    1.5 Global Home and Alternate Site Infusion Therapy Market Size and Forecast by Region
        1.5.1 Global Home and Alternate Site Infusion Therapy Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Home and Alternate Site Infusion Therapy Market Size by Region, (2017-2022)
        1.5.3 North America Home and Alternate Site Infusion Therapy Market Size and Prospect (2017-2028)
        1.5.4 Europe Home and Alternate Site Infusion Therapy Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Home and Alternate Site Infusion Therapy Market Size and Prospect (2017-2028)
        1.5.6 South America Home and Alternate Site Infusion Therapy Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Home and Alternate Site Infusion Therapy Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Home and Alternate Site Infusion Therapy Market Drivers
        1.6.2 Home and Alternate Site Infusion Therapy Market Restraints
        1.6.3 Home and Alternate Site Infusion Therapy Trends Analysis

2 Company Profiles
    2.1 Option Care Health
        2.1.1 Option Care Health Details
        2.1.2 Option Care Health Major Business
        2.1.3 Option Care Health Home and Alternate Site Infusion Therapy Product and Solutions
        2.1.4 Option Care Health Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Option Care Health Recent Developments and Future Plans
    2.2 Coram CVS
        2.2.1 Coram CVS Details
        2.2.2 Coram CVS Major Business
        2.2.3 Coram CVS Home and Alternate Site Infusion Therapy Product and Solutions
        2.2.4 Coram CVS Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Coram CVS Recent Developments and Future Plans
    2.3 UnitedHealth Group
        2.3.1 UnitedHealth Group Details
        2.3.2 UnitedHealth Group Major Business
        2.3.3 UnitedHealth Group Home and Alternate Site Infusion Therapy Product and Solutions
        2.3.4 UnitedHealth Group Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 UnitedHealth Group Recent Developments and Future Plans
    2.4 HCA Healthcare
        2.4.1 HCA Healthcare Details
        2.4.2 HCA Healthcare Major Business
        2.4.3 HCA Healthcare Home and Alternate Site Infusion Therapy Product and Solutions
        2.4.4 HCA Healthcare Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 HCA Healthcare Recent Developments and Future Plans
    2.5 McLaren
        2.5.1 McLaren Details
        2.5.2 McLaren Major Business
        2.5.3 McLaren Home and Alternate Site Infusion Therapy Product and Solutions
        2.5.4 McLaren Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 McLaren Recent Developments and Future Plans
    2.6 CHI Health
        2.6.1 CHI Health Details
        2.6.2 CHI Health Major Business
        2.6.3 CHI Health Home and Alternate Site Infusion Therapy Product and Solutions
        2.6.4 CHI Health Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 CHI Health Recent Developments and Future Plans
    2.7 Accredo Health
        2.7.1 Accredo Health Details
        2.7.2 Accredo Health Major Business
        2.7.3 Accredo Health Home and Alternate Site Infusion Therapy Product and Solutions
        2.7.4 Accredo Health Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Accredo Health Recent Developments and Future Plans
    2.8 PharMerica
        2.8.1 PharMerica Details
        2.8.2 PharMerica Major Business
        2.8.3 PharMerica Home and Alternate Site Infusion Therapy Product and Solutions
        2.8.4 PharMerica Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 PharMerica Recent Developments and Future Plans
    2.9 Cleveland Clinic
        2.9.1 Cleveland Clinic Details
        2.9.2 Cleveland Clinic Major Business
        2.9.3 Cleveland Clinic Home and Alternate Site Infusion Therapy Product and Solutions
        2.9.4 Cleveland Clinic Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Cleveland Clinic Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Home and Alternate Site Infusion Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Home and Alternate Site Infusion Therapy Players Market Share in 2021
        3.2.2 Top 10 Home and Alternate Site Infusion Therapy Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Home and Alternate Site Infusion Therapy Players Head Office, Products and Services Provided
    3.4 Home and Alternate Site Infusion Therapy Mergers & Acquisitions
    3.5 Home and Alternate Site Infusion Therapy New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Home and Alternate Site Infusion Therapy Revenue and Market Share by Type (2017-2022)
    4.2 Global Home and Alternate Site Infusion Therapy Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
    5.1 Global Home and Alternate Site Infusion Therapy Revenue Market Share by Application (2017-2022)
    5.2 Global Home and Alternate Site Infusion Therapy Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
    6.1 North America Home and Alternate Site Infusion Therapy Revenue by Type (2017-2028)
    6.2 North America Home and Alternate Site Infusion Therapy Revenue by Application (2017-2028)
    6.3 North America Home and Alternate Site Infusion Therapy Market Size by Country
        6.3.1 North America Home and Alternate Site Infusion Therapy Revenue by Country (2017-2028)
        6.3.2 United States Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)
        6.3.3 Canada Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)
        6.3.4 Mexico Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
    7.1 Europe Home and Alternate Site Infusion Therapy Revenue by Type (2017-2028)
    7.2 Europe Home and Alternate Site Infusion Therapy Revenue by Application (2017-2028)
    7.3 Europe Home and Alternate Site Infusion Therapy Market Size by Country
        7.3.1 Europe Home and Alternate Site Infusion Therapy Revenue by Country (2017-2028)
        7.3.2 Germany Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)
        7.3.3 France Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)
        7.3.5 Russia Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)
        7.3.6 Italy Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Type (2017-2028)
    8.2 Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Application (2017-2028)
    8.3 Asia-Pacific Home and Alternate Site Infusion Therapy Market Size by Region
        8.3.1 Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Region (2017-2028)
        8.3.2 China Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)
        8.3.3 Japan Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)
        8.3.4 South Korea Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)
        8.3.5 India Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)
        8.3.7 Australia Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
    9.1 South America Home and Alternate Site Infusion Therapy Revenue by Type (2017-2028)
    9.2 South America Home and Alternate Site Infusion Therapy Revenue by Application (2017-2028)
    9.3 South America Home and Alternate Site Infusion Therapy Market Size by Country
        9.3.1 South America Home and Alternate Site Infusion Therapy Revenue by Country (2017-2028)
        9.3.2 Brazil Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)
        9.3.3 Argentina Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Type (2017-2028)
    10.2 Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Application (2017-2028)
    10.3 Middle East & Africa Home and Alternate Site Infusion Therapy Market Size by Country
        10.3.1 Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Country (2017-2028)
        10.3.2 Turkey Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)
        10.3.4 UAE Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Home and Alternate Site Infusion Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Home and Alternate Site Infusion Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Home and Alternate Site Infusion Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Home and Alternate Site Infusion Therapy Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Home and Alternate Site Infusion Therapy Revenue Market Share by Region (2023-2028)
    Table 6. Option Care Health Corporate Information, Head Office, and Major Competitors
    Table 7. Option Care Health Major Business
    Table 8. Option Care Health Home and Alternate Site Infusion Therapy Product and Solutions
    Table 9. Option Care Health Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. Coram CVS Corporate Information, Head Office, and Major Competitors
    Table 11. Coram CVS Major Business
    Table 12. Coram CVS Home and Alternate Site Infusion Therapy Product and Solutions
    Table 13. Coram CVS Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. UnitedHealth Group Corporate Information, Head Office, and Major Competitors
    Table 15. UnitedHealth Group Major Business
    Table 16. UnitedHealth Group Home and Alternate Site Infusion Therapy Product and Solutions
    Table 17. UnitedHealth Group Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. HCA Healthcare Corporate Information, Head Office, and Major Competitors
    Table 19. HCA Healthcare Major Business
    Table 20. HCA Healthcare Home and Alternate Site Infusion Therapy Product and Solutions
    Table 21. HCA Healthcare Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. McLaren Corporate Information, Head Office, and Major Competitors
    Table 23. McLaren Major Business
    Table 24. McLaren Home and Alternate Site Infusion Therapy Product and Solutions
    Table 25. McLaren Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. CHI Health Corporate Information, Head Office, and Major Competitors
    Table 27. CHI Health Major Business
    Table 28. CHI Health Home and Alternate Site Infusion Therapy Product and Solutions
    Table 29. CHI Health Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. Accredo Health Corporate Information, Head Office, and Major Competitors
    Table 31. Accredo Health Major Business
    Table 32. Accredo Health Home and Alternate Site Infusion Therapy Product and Solutions
    Table 33. Accredo Health Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. PharMerica Corporate Information, Head Office, and Major Competitors
    Table 35. PharMerica Major Business
    Table 36. PharMerica Home and Alternate Site Infusion Therapy Product and Solutions
    Table 37. PharMerica Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. Cleveland Clinic Corporate Information, Head Office, and Major Competitors
    Table 39. Cleveland Clinic Major Business
    Table 40. Cleveland Clinic Home and Alternate Site Infusion Therapy Product and Solutions
    Table 41. Cleveland Clinic Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. Global Home and Alternate Site Infusion Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 43. Global Home and Alternate Site Infusion Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 44. Breakdown of Home and Alternate Site Infusion Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 45. Home and Alternate Site Infusion Therapy Players Head Office, Products and Services Provided
    Table 46. Home and Alternate Site Infusion Therapy Mergers & Acquisitions in the Past Five Years
    Table 47. Home and Alternate Site Infusion Therapy New Entrants and Expansion Plans
    Table 48. Global Home and Alternate Site Infusion Therapy Revenue (USD Million) by Type (2017-2022)
    Table 49. Global Home and Alternate Site Infusion Therapy Revenue Share by Type (2017-2022)
    Table 50. Global Home and Alternate Site Infusion Therapy Revenue Forecast by Type (2023-2028)
    Table 51. Global Home and Alternate Site Infusion Therapy Revenue by Application (2017-2022)
    Table 52. Global Home and Alternate Site Infusion Therapy Revenue Forecast by Application (2023-2028)
    Table 53. North America Home and Alternate Site Infusion Therapy Revenue by Type (2017-2022) & (USD Million)
    Table 54. North America Home and Alternate Site Infusion Therapy Revenue by Type (2023-2028) & (USD Million)
    Table 55. North America Home and Alternate Site Infusion Therapy Revenue by Application (2017-2022) & (USD Million)
    Table 56. North America Home and Alternate Site Infusion Therapy Revenue by Application (2023-2028) & (USD Million)
    Table 57. North America Home and Alternate Site Infusion Therapy Revenue by Country (2017-2022) & (USD Million)
    Table 58. North America Home and Alternate Site Infusion Therapy Revenue by Country (2023-2028) & (USD Million)
    Table 59. Europe Home and Alternate Site Infusion Therapy Revenue by Type (2017-2022) & (USD Million)
    Table 60. Europe Home and Alternate Site Infusion Therapy Revenue by Type (2023-2028) & (USD Million)
    Table 61. Europe Home and Alternate Site Infusion Therapy Revenue by Application (2017-2022) & (USD Million)
    Table 62. Europe Home and Alternate Site Infusion Therapy Revenue by Application (2023-2028) & (USD Million)
    Table 63. Europe Home and Alternate Site Infusion Therapy Revenue by Country (2017-2022) & (USD Million)
    Table 64. Europe Home and Alternate Site Infusion Therapy Revenue by Country (2023-2028) & (USD Million)
    Table 65. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Type (2017-2022) & (USD Million)
    Table 66. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Type (2023-2028) & (USD Million)
    Table 67. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Application (2017-2022) & (USD Million)
    Table 68. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Application (2023-2028) & (USD Million)
    Table 69. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Region (2017-2022) & (USD Million)
    Table 70. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Region (2023-2028) & (USD Million)
    Table 71. South America Home and Alternate Site Infusion Therapy Revenue by Type (2017-2022) & (USD Million)
    Table 72. South America Home and Alternate Site Infusion Therapy Revenue by Type (2023-2028) & (USD Million)
    Table 73. South America Home and Alternate Site Infusion Therapy Revenue by Application (2017-2022) & (USD Million)
    Table 74. South America Home and Alternate Site Infusion Therapy Revenue by Application (2023-2028) & (USD Million)
    Table 75. South America Home and Alternate Site Infusion Therapy Revenue by Country (2017-2022) & (USD Million)
    Table 76. South America Home and Alternate Site Infusion Therapy Revenue by Country (2023-2028) & (USD Million)
    Table 77. Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Type (2017-2022) & (USD Million)
    Table 78. Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Type (2023-2028) & (USD Million)
    Table 79. Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Application (2017-2022) & (USD Million)
    Table 80. Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Application (2023-2028) & (USD Million)
    Table 81. Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Country (2017-2022) & (USD Million)
    Table 82. Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Home and Alternate Site Infusion Therapy Picture
    Figure 2. Global Home and Alternate Site Infusion Therapy Revenue Market Share by Type in 2021
    Figure 3. Chemotherapy
    Figure 4. Anti-infective Therapies
    Figure 5. Immune Therapy
    Figure 6. General Nursing Services
    Figure 7. Others
    Figure 8. Home and Alternate Site Infusion Therapy Revenue Market Share by Application in 2021
    Figure 9. Residential Picture
    Figure 10. Ambulatory Infusion Centers Picture
    Figure 11. Others Picture
    Figure 12. Global Home and Alternate Site Infusion Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 13. Global Home and Alternate Site Infusion Therapy Revenue and Forecast (2017-2028) & (USD Million)
    Figure 14. Global Home and Alternate Site Infusion Therapy Revenue Market Share by Region (2017-2028)
    Figure 15. Global Home and Alternate Site Infusion Therapy Revenue Market Share by Region in 2021
    Figure 16. North America Home and Alternate Site Infusion Therapy Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 17. Europe Home and Alternate Site Infusion Therapy Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 18. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 19. South America Home and Alternate Site Infusion Therapy Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 20. Middle East and Africa Home and Alternate Site Infusion Therapy Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 21. Home and Alternate Site Infusion Therapy Market Drivers
    Figure 22. Home and Alternate Site Infusion Therapy Market Restraints
    Figure 23. Home and Alternate Site Infusion Therapy Market Trends
    Figure 24. Option Care Health Recent Developments and Future Plans
    Figure 25. Coram CVS Recent Developments and Future Plans
    Figure 26. UnitedHealth Group Recent Developments and Future Plans
    Figure 27. HCA Healthcare Recent Developments and Future Plans
    Figure 28. McLaren Recent Developments and Future Plans
    Figure 29. CHI Health Recent Developments and Future Plans
    Figure 30. Accredo Health Recent Developments and Future Plans
    Figure 31. PharMerica Recent Developments and Future Plans
    Figure 32. Cleveland Clinic Recent Developments and Future Plans
    Figure 33. Global Home and Alternate Site Infusion Therapy Revenue Share by Players in 2021
    Figure 34. Home and Alternate Site Infusion Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 35. Global Top 3 Players Home and Alternate Site Infusion Therapy Revenue Market Share in 2021
    Figure 36. Global Top 10 Players Home and Alternate Site Infusion Therapy Revenue Market Share in 2021
    Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 38. Global Home and Alternate Site Infusion Therapy Revenue Share by Type in 2021
    Figure 39. Global Home and Alternate Site Infusion Therapy Market Share Forecast by Type (2023-2028)
    Figure 40. Global Home and Alternate Site Infusion Therapy Revenue Share by Application in 2021
    Figure 41. Global Home and Alternate Site Infusion Therapy Market Share Forecast by Application (2023-2028)
    Figure 42. North America Home and Alternate Site Infusion Therapy Sales Market Share by Type (2017-2028)
    Figure 43. North America Home and Alternate Site Infusion Therapy Sales Market Share by Application (2017-2028)
    Figure 44. North America Home and Alternate Site Infusion Therapy Revenue Market Share by Country (2017-2028)
    Figure 45. United States Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 46. Canada Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 47. Mexico Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. Europe Home and Alternate Site Infusion Therapy Sales Market Share by Type (2017-2028)
    Figure 49. Europe Home and Alternate Site Infusion Therapy Sales Market Share by Application (2017-2028)
    Figure 50. Europe Home and Alternate Site Infusion Therapy Revenue Market Share by Country (2017-2028)
    Figure 51. Germany Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. France Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. United Kingdom Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 54. Russia Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 55. Italy Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 56. Asia-Pacific Home and Alternate Site Infusion Therapy Sales Market Share by Type (2017-2028)
    Figure 57. Asia-Pacific Home and Alternate Site Infusion Therapy Sales Market Share by Application (2017-2028)
    Figure 58. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue Market Share by Region (2017-2028)
    Figure 59. China Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Japan Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. South Korea Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. India Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. Southeast Asia Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. Australia Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 65. South America Home and Alternate Site Infusion Therapy Sales Market Share by Type (2017-2028)
    Figure 66. South America Home and Alternate Site Infusion Therapy Sales Market Share by Application (2017-2028)
    Figure 67. South America Home and Alternate Site Infusion Therapy Revenue Market Share by Country (2017-2028)
    Figure 68. Brazil Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 69. Argentina Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 70. Middle East and Africa Home and Alternate Site Infusion Therapy Sales Market Share by Type (2017-2028)
    Figure 71. Middle East and Africa Home and Alternate Site Infusion Therapy Sales Market Share by Application (2017-2028)
    Figure 72. Middle East and Africa Home and Alternate Site Infusion Therapy Revenue Market Share by Country (2017-2028)
    Figure 73. Turkey Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Saudi Arabia Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. UAE Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Methodology
    Figure 77. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Option Care Health
Coram CVS
UnitedHealth Group
HCA Healthcare
McLaren
CHI Health
Accredo Health
PharMerica
Cleveland Clinic

Related Reports

Global Home and Alternate Site Infusion Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Home and Alternate Site Infusion Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 02 Feb 2021

date Medical Devices & Consumables

The Home and Alternate Site Infusion Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Product Tags

home alternate site infusion therapy

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>